UA19162A - Спосіб одержаhhя аhтибіотика s541, штами стрептоміцетів - продуцеhти аhтибіотика s541 - Google Patents

Спосіб одержаhhя аhтибіотика s541, штами стрептоміцетів - продуцеhти аhтибіотика s541

Info

Publication number
UA19162A
UA19162A UA3957807A UA3957807A UA19162A UA 19162 A UA19162 A UA 19162A UA 3957807 A UA3957807 A UA 3957807A UA 3957807 A UA3957807 A UA 3957807A UA 19162 A UA19162 A UA 19162A
Authority
UA
Ukraine
Prior art keywords
antibiotic
nc1b
preparation
producers
methyl
Prior art date
Application number
UA3957807A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Варрі Уорд Джон
Мері Hоубл Хейзл
Портер Hейл
Алан Флеттон Річард
Hоубл Девід
Original Assignee
Глексо Груп Лімітед
Глексо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848423278A external-priority patent/GB8423278D0/en
Priority claimed from GB848432519A external-priority patent/GB8432519D0/en
Application filed by Глексо Груп Лімітед, Глексо Груп Лимитед filed Critical Глексо Груп Лімітед
Publication of UA19162A publication Critical patent/UA19162A/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
UA3957807A 1984-09-14 1985-09-13 Спосіб одержаhhя аhтибіотика s541, штами стрептоміцетів - продуцеhти аhтибіотика s541 UA19162A (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848423278A GB8423278D0 (en) 1984-09-14 1984-09-14 Antibiotic compounds
GB848432519A GB8432519D0 (en) 1984-12-21 1984-12-21 Antibiotic compounds

Publications (1)

Publication Number Publication Date
UA19162A true UA19162A (uk) 1997-12-25

Family

ID=26288220

Family Applications (1)

Application Number Title Priority Date Filing Date
UA3957807A UA19162A (uk) 1984-09-14 1985-09-13 Спосіб одержаhhя аhтибіотика s541, штами стрептоміцетів - продуцеhти аhтибіотика s541

Country Status (33)

Country Link
US (2) US4898821A (US06650917-20031118-M00005.png)
JP (2) JPH07116199B2 (US06650917-20031118-M00005.png)
KR (1) KR940004098B1 (US06650917-20031118-M00005.png)
AT (1) AT396250B (US06650917-20031118-M00005.png)
AU (1) AU596565B2 (US06650917-20031118-M00005.png)
BE (1) BE903232A (US06650917-20031118-M00005.png)
BG (1) BG44205A3 (US06650917-20031118-M00005.png)
BR (1) BR8504457A (US06650917-20031118-M00005.png)
CA (1) CA1313155C (US06650917-20031118-M00005.png)
CH (1) CH666690A5 (US06650917-20031118-M00005.png)
CS (1) CS268803B2 (US06650917-20031118-M00005.png)
DE (1) DE3532794A1 (US06650917-20031118-M00005.png)
DK (1) DK162099C (US06650917-20031118-M00005.png)
ES (2) ES8704545A1 (US06650917-20031118-M00005.png)
FI (1) FI87366C (US06650917-20031118-M00005.png)
FR (1) FR2570390B1 (US06650917-20031118-M00005.png)
GB (1) GB2166436B (US06650917-20031118-M00005.png)
GR (1) GR852232B (US06650917-20031118-M00005.png)
HU (1) HU197046B (US06650917-20031118-M00005.png)
IE (1) IE59394B1 (US06650917-20031118-M00005.png)
IL (1) IL76385A (US06650917-20031118-M00005.png)
IT (1) IT1182857B (US06650917-20031118-M00005.png)
LU (1) LU86074A1 (US06650917-20031118-M00005.png)
NL (1) NL8502511A (US06650917-20031118-M00005.png)
NZ (1) NZ213463A (US06650917-20031118-M00005.png)
PH (2) PH21995A (US06650917-20031118-M00005.png)
PL (1) PL152148B1 (US06650917-20031118-M00005.png)
PT (1) PT81125B (US06650917-20031118-M00005.png)
RO (1) RO92478A (US06650917-20031118-M00005.png)
SE (2) SE502748C2 (US06650917-20031118-M00005.png)
SU (1) SU1738090A3 (US06650917-20031118-M00005.png)
UA (1) UA19162A (US06650917-20031118-M00005.png)
ZW (1) ZW15585A1 (US06650917-20031118-M00005.png)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV5536A3 (lv) * 1984-09-14 1994-03-10 American Cyanamid Co Panemiens antibiotikas s-541 iegusanai streptomicetu celmi-antibiotikas s-541 producenti
US4696922A (en) * 1984-11-26 1987-09-29 Ciba-Geigy Corporation 5-azolylacetoxymilbemycins as ecto- and endoparasites
AT399441B (de) * 1985-04-30 1995-05-26 American Cyanamid Co Schädlingsbekämpfungsmittel und verfahren zur bekämpfung von schädlingen
ES8802229A1 (es) * 1985-04-30 1988-04-16 Glaxo Group Ltd Un procedimiento para preparar nuevos derivados lactonicos macrociclicos.
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
DE3650265T2 (de) * 1985-09-13 1995-07-27 American Cyanamid Co Makrolide Antibiotika und Verfahren zu deren Herstellung.
GB8606105D0 (en) * 1986-03-12 1986-04-16 Glaxo Group Ltd Chemical compounds
EP0238259B1 (en) * 1986-03-12 1993-09-29 American Cyanamid Company Macrolide compounds
GB8606120D0 (en) * 1986-03-12 1986-04-16 Glaxo Group Ltd Process
GB8606116D0 (en) * 1986-03-12 1986-04-16 Glaxo Group Ltd Process
IT1205746B (it) * 1986-03-12 1989-03-31 Glaxo Group Ltd Composto antibiotico,composizioni che lo contengono e relativo metodo di preparazione e applicazione
AT398312B (de) * 1986-03-12 1994-11-25 American Cyanamid Co Verfahren zur herstellung einer neuen makroliden verbindung
GB8613790D0 (en) * 1986-06-06 1986-07-09 Glaxo Group Ltd Chemical compounds
CA1296329C (en) * 1986-06-06 1992-02-25 Derek R. Sutherland Macrolide compounds
US5840704A (en) * 1986-07-16 1998-11-24 Pfizer Inc. Antiparasitic agents and process for their preparation
EP0253378A3 (de) * 1986-07-18 1988-03-23 Ciba-Geigy Ag 13Beta-Alkyl-derivate von S541-Antibiotika zur Bekämpfung von Parasiten an Nutztieren und Pflanzen
JP2587241B2 (ja) * 1986-07-24 1997-03-05 ビ−チヤム・グル−プ・ピ−エルシ− 新規化合物、その製法及びそれを含む医薬組成物
US4886828A (en) * 1986-09-12 1989-12-12 American Cyanamid Company Δ22 -derivatives of LL-F28249 compounds
US4916154A (en) * 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
US5149832A (en) * 1986-09-12 1992-09-22 American Cyanamid Company Mono and diacyl derivatives of ll-f28249 compounds
DE3750355T2 (de) * 1986-09-12 1995-04-06 American Cyanamid Co 23-Oxo(keto) und 23-Imino-Derivate von LL-F28249-Verbindungen.
DE3782481T2 (de) * 1986-09-12 1993-05-19 American Cyanamid Co 23-deoxy-derivate von ll-f28249-verbindungen.
US5019589A (en) * 1986-09-12 1991-05-28 American Cyanamid Company Δ23 -LL-F28249 compounds
US5525506A (en) * 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5238848A (en) * 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5234831A (en) * 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5183749A (en) * 1987-02-04 1993-02-02 Sankyo Company, Ltd. Microbial process for the preparation of milbemycin derivatives
US4897416A (en) * 1987-02-18 1990-01-30 Ciba-Geigy Corporation Insecticides and parasiticides
US4851428A (en) * 1987-03-06 1989-07-25 American Cyanamid Company Mono- and diepoxide derivatives of Δ22-LL-F28249 compounds
US4956479A (en) * 1987-03-06 1990-09-11 American Cyanamid Company 23-deoxy-27-chloro derivatives of LL-F28249 compounds
US4876272A (en) * 1987-03-06 1989-10-24 American Cyanamid Company Mono- and diepoxide derivatives of LL-F28249 compounds
US4886830A (en) * 1987-03-06 1989-12-12 American Cyanamid Company Mono- and diepoxide derivatives of 23-deoxyl-LL-F28249 compounds
US4855317A (en) * 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4886829A (en) * 1987-03-06 1989-12-12 American Cyanamid Company 23-Oxo (keto) and 23-imino derivatives of mono- and diepoxy LL-F28249 compounds
US4806527A (en) * 1987-03-16 1989-02-21 Merck & Co., Inc. Avermectin derivatives
US4871719A (en) * 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
EP0285561A3 (de) * 1987-03-27 1989-10-25 Ciba-Geigy Ag Parasitizide und insektizide Milbemycin-Derivate
GB8721378D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical process
GB8721375D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical process
GB8721377D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical compounds
GB8721647D0 (en) * 1987-09-15 1987-10-21 Pfizer Ltd Antiparasitic agents
US5240850A (en) * 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
ATE87926T1 (de) * 1987-11-09 1993-04-15 Pfizer Ethylierte avermectine.
GB8726730D0 (en) 1987-11-14 1987-12-16 Pfizer Ltd Antiparasitic agents
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
GB8804440D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Antiparasitic agents
GB8805978D0 (en) * 1988-03-14 1988-04-13 Glaxo Group Ltd Process
GB8813760D0 (en) * 1988-06-10 1988-07-13 American Cyanamid Co Chemical process
NZ232422A (en) * 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
US5322692A (en) * 1989-02-28 1994-06-21 American Cyanamid Company Sustained release bolus effective for the prolonged prevention, treatment or control of nematode, acarid and endo- and ectoparasitic infestations of ruminants
EP0393890B1 (en) * 1989-04-11 1992-08-12 Pfizer Limited Injectable compositions containing 25-cyclohexyl-avermectin b1
US6001822A (en) * 1989-04-11 1999-12-14 Pfizer Inc. Antiparasitic formulations
ES2087099T3 (es) 1989-08-11 1996-07-16 American Cyanamid Co Agentes arilpirrolicos insecticidas, acaricidas y nematicidas y procedimientos.
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US5055454A (en) * 1989-10-30 1991-10-08 Merck & Co., Inc. 13-epi-avermectin derivatives useful as antiparasitic agents
US5830875A (en) * 1989-10-30 1998-11-03 Merck & Co., Inc. 24-and 25-substituted avermectin and milbemycin derivatives
US5208222A (en) * 1991-03-28 1993-05-04 Merck & Co., Inc. 4"-and 4'-alkylthio avermectin derivatives
US5262400A (en) * 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
MD24C2 (ro) * 1991-07-09 1994-05-31 Fabrica De Parfumerii Si Cosmetica "Viorica" Compoziţie de substanţe odorante
GB9205007D0 (en) * 1992-03-07 1992-04-22 Pfizer Ltd Antiparasitic agents
US5229415A (en) * 1992-03-24 1993-07-20 Merck & Co., Inc. Alkylthio alkyl avermectins are active antiparasitic agents
US6103504A (en) * 1992-03-25 2000-08-15 Pfizer Inc. Process for production of avermectins and cultures therefor
US6486195B1 (en) * 1993-08-19 2002-11-26 Merck & Co., Inc. Thermodynamically stable crystal form of 4″-deoxy-4″-epi-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation
JP2855181B2 (ja) 1993-12-10 1999-02-10 敏雄 鈴木 松類の枯損防止用組成物及び防止方法
WO1999017760A2 (en) 1997-10-02 1999-04-15 Microcide Pharmaceuticals, Inc. Fungal or mammalian cell efflux pump inhibitors for enhancing susceptibility of the cell to a drug
PT1197215E (pt) 2000-10-10 2006-07-31 Wyeth Corp Composicoes antelminticas
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
JP2008531553A (ja) * 2005-02-25 2008-08-14 メディジーンズ カンパニー リミテッド 血漿または血清を含むアベリノ角膜ジストロフィー治療用の医薬組成物
CN100394983C (zh) * 2006-01-09 2008-06-18 浙江海正药业股份有限公司 含有大豆油的多拉菌素注射液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (US06650917-20031118-M00005.png) * 1972-06-08 1974-02-08
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4173571A (en) * 1977-12-19 1979-11-06 Merck & Co., Inc. 13-Halo and 13-deoxy derivatives of C-076 compounds
US4171314A (en) * 1977-12-19 1979-10-16 Merck & Co., Inc. 13-Halo and 13-deoxy C-076 compounds
PH16612A (en) * 1977-12-19 1983-11-28 Merck & Co Inc 13-halo and 13-deoxy derivatives of c-076 compounds
US4200581A (en) * 1978-08-04 1980-04-29 Merck & Co., Inc. Alkyl derivatives of C-076 compounds
NZ201681A (en) * 1981-09-03 1985-11-08 Merck & Co Inc Avermectin derivatives and parasiticidal compositions
DE3519834C2 (de) * 1984-06-05 1993-12-16 American Cyanamid Co Neue antibiotische Wirkstoffe, Verfahren zu ihrer Gewinnung und ihre Anwendung zur Bekämpfung von Infektionen bei Tieren und Pflanzen
ES8802229A1 (es) * 1985-04-30 1988-04-16 Glaxo Group Ltd Un procedimiento para preparar nuevos derivados lactonicos macrociclicos.
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina

Also Published As

Publication number Publication date
GB2166436A (en) 1986-05-08
CA1313155C (en) 1993-01-26
DE3532794A1 (de) 1986-04-17
ES8802555A1 (es) 1988-08-01
FR2570390A1 (fr) 1986-03-21
AT396250B (de) 1993-07-26
FI853520A0 (fi) 1985-09-13
RO92478A (ro) 1987-09-30
PH24247A (en) 1990-05-04
PH21995A (en) 1988-05-02
ES557237A0 (es) 1988-08-01
GR852232B (US06650917-20031118-M00005.png) 1986-01-14
SE8802985D0 (sv) 1988-08-25
DK162099B (da) 1991-09-16
CH666690A5 (de) 1988-08-15
US4935531A (en) 1990-06-19
IL76385A (en) 1990-09-17
GB2166436B (en) 1989-05-24
DK418085A (da) 1986-03-15
CS268803B2 (en) 1990-04-11
NZ213463A (en) 1993-04-28
IE59394B1 (en) 1994-02-23
SE8802985L (sv) 1988-08-25
BE903232A (fr) 1986-03-13
KR860002576A (ko) 1986-04-26
ES546962A0 (es) 1987-04-01
JPS61118387A (ja) 1986-06-05
HUT39779A (en) 1986-10-29
NL8502511A (nl) 1986-04-01
PT81125A (en) 1985-10-01
IE852263L (en) 1986-03-14
CS654685A2 (en) 1989-08-14
KR940004098B1 (ko) 1994-05-13
JPH07116199B2 (ja) 1995-12-13
US4898821A (en) 1990-02-06
FI87366B (fi) 1992-09-15
IT1182857B (it) 1987-10-05
PL255360A1 (en) 1988-02-18
BG44205A3 (en) 1988-10-14
FI853520L (fi) 1986-03-15
JPH07213278A (ja) 1995-08-15
DK162099C (da) 1992-02-24
SU1738090A3 (ru) 1992-05-30
DK418085D0 (da) 1985-09-13
SE469173B (sv) 1993-05-24
SE8504254L (sv) 1986-03-15
ES8704545A1 (es) 1987-04-01
BR8504457A (pt) 1986-07-15
IT8548551A0 (it) 1985-09-13
GB8522699D0 (en) 1985-10-16
SE502748C2 (sv) 1995-12-18
FI87366C (fi) 1992-12-28
JP2566385B2 (ja) 1996-12-25
IL76385A0 (en) 1986-01-31
ZW15585A1 (en) 1986-04-23
SE8504254D0 (sv) 1985-09-13
PT81125B (pt) 1987-10-20
ATA268485A (de) 1992-11-15
PL152148B1 (en) 1990-11-30
AU596565B2 (en) 1990-05-10
HU197046B (en) 1989-02-28
FR2570390B1 (fr) 1987-11-27
AU4742685A (en) 1986-03-20
LU86074A1 (fr) 1986-04-03

Similar Documents

Publication Publication Date Title
UA19162A (uk) Спосіб одержаhhя аhтибіотика s541, штами стрептоміцетів - продуцеhти аhтибіотика s541
EP0029329A3 (en) Enzyme inhibitor produced by cultivation of streptomyces microorganisms, a process for producing it and a culture of the microorganism
DK161091C (da) Svovlholdige antibiotiske forbindelser med antitumorvirkning, betegnet cl-1577a og cl-1577b, fremgangsmaade til fremstilling deraf, samt farmaceutiske praeparater indeholdende forbindelserne
UA13320A (uk) Спосіб одержаhhя комплексhого аhтибіотика циклоспоріhу та/або його компоhеhтів та штам грибка tolypocladium varium
ES8105149A1 (es) Un procedimiento para la preparacion de la mezcla antibioti-ca a-42355
PL309613A1 (en) Method of obtaining immunosuppressants and novel species of microorganism for use in that method
ES475178A1 (es) Un metodo mejorado para producir antibiotico c-15003 p-3.
HUT39208A (en) Process for producing antibiotic complex aad 216 and main components thereof by means of fermentation with kibdelosporangium aridum
GB1474129A (en) Method for the production of d-ribose
ES8606488A1 (es) Un metodo para cultivar microorganismos en un medio nutricio
IE45501L (en) Antibiotic a-35512.
ES8304202A1 (es) Un metodo de produccion del antibiotico narasina.
ES8603572A1 (es) Procedimiento para producir un vector hibrido
IE45014L (en) Antibiotic a-7413.
IL88088A0 (en) Microbiological process for making uk-61,689 and microorganisms useful therefor
ES485529A1 (es) Un procedimiento para la produccion de ravidomicina
GB1430558A (en) Process for producing inosine-5,-monophosphate
JPS6422861A (en) New substance ag55-2
GEP19971048B (en) Method for preparation of antibiotic s541 and streptomycetes strains-producers of antibiotic s541
BG40817A3 (en) Method for preparation of macrolidic antibiotics
EP0136923A3 (en) 2-amino-1,9-dihydro-6h-purin-6-one-7-oxide, the pharmaceutically acceptable salts and a process for the production thereof
JPS5794288A (en) Aristeromycin-producing bactria
ES8405439A1 (es) Procedimiento para producir acido clavulanico.
AU631651B2 (en) Method for culturing cells
MD96C2 (ro) Procedeu de obţinere a antibioticului S541, tulpini ale streptomicetelor-producenţii antibioticului S541